Colorectal cancer displays the most diverse profile of KRAS mutants with 28% of CRCs harboring a G12D mutation, 20% of CRCs harboring a G12V mutation, and 16% of CRCs harboring a G13D mutation (CITE). The gene discussed is KRAS; the disease is colorectal cancer.